Clinical Trials | October 27, 2022
Camizestrant significantly improved PFS vs. Faslodex in SERENA-2 Phase II trial
Results reinforce commitment to next-generation oral SERD development programme
Results reinforce commitment to next-generation oral SERD development programme
CHMP positive opinion is based on evidence from the EFFISAYIL trial, the largest clinical trial in
This will dramatically improve timely intervention with the right experts thus ensuring significant improvement in patient’s condition management and health outcome
Sotatercept demonstrated significant improvement in exercise capacity and key secondary outcome measures compared to placebo when added to background therapy
Study achieves primary endpoint of radiographic progression-free survival
Patients with moderate or elevated risk in the test should immediately consult a cardiologist for further diagnosis and workup
One in two women with advanced ovarian cancer has an HRD-positive tumor
The drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ, India
Rymti is indicated in the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, axial spondyloarthritis, plaque psoriasis, and paediatric plaque psoriasis
The funding round also saw participation from some of India's top angel investors and leading industry giants
Subscribe To Our Newsletter & Stay Updated
